Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-43.68	-250.43	444.65
Graham Fair Price	75.46	3.44	1.96
PEG	-84.12	-0.17	1.10
Price/Book	30.61	25.65	19.64
Price/Cash Flow	-40.57	-197.92	333.05
Prices/Earnings	59.58	-37.37	-92.45
Price/Sales	35.30	18.14	13.41
Price/FCF	-40.57	-197.92	333.05
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-5.28	0.40	0.42
Operating Margin	-710.47	-0.12	-0.01
ROA	-231.63	-0.04	-0.01
ROE	-0.05	-0.17	-223.09
ROIC	-0.01	-0.07	-555.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-62.69
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.94	-6.74	618.69
EPS QOQ	0.84	-2.15	154.57
FCF QOQ	-0.53	-3.17	-498.68
Revenue QOQ	0.56	-0.05	-91.87
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	25.54	24.46	-4.25
Inventory Turnover	0.00	710069000.00	100.00
Debt/Capitalization	0.60	0.60	0.46
Quick Ratio	1.05	1.06	0.44
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.80	1.75	-2.39
Cash	2.74	2.54	-7.23
Capex	-0.05	-0.08	-63.40
Free Cash Flow	0.11	-0.23	114.53
Revenue	2.63	2.48	-5.77
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.34	1.34	0.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.71	-1.63	-5.03
Naive Interpretation	Member

06 - Financial Health · Weak

Rating